share_log

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development

Larimar Therapeutics | 8-K: Current report

Larimar Therapeutics | 8-K:重大事件
美股sec公告 ·  03/14 16:10
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息